Correlation Between Amgen and Afya
Can any of the company-specific risk be diversified away by investing in both Amgen and Afya at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Amgen and Afya into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Amgen Inc and Afya, you can compare the effects of market volatilities on Amgen and Afya and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Amgen with a short position of Afya. Check out your portfolio center. Please also check ongoing floating volatility patterns of Amgen and Afya.
Diversification Opportunities for Amgen and Afya
Weak diversification
The 3 months correlation between Amgen and Afya is 0.38. Overlapping area represents the amount of risk that can be diversified away by holding Amgen Inc and Afya in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Afya and Amgen is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Amgen Inc are associated (or correlated) with Afya. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Afya has no effect on the direction of Amgen i.e., Amgen and Afya go up and down completely randomly.
Pair Corralation between Amgen and Afya
Given the investment horizon of 90 days Amgen is expected to generate 1.06 times less return on investment than Afya. But when comparing it to its historical volatility, Amgen Inc is 1.63 times less risky than Afya. It trades about 0.02 of its potential returns per unit of risk. Afya is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest 1,549 in Afya on September 15, 2024 and sell it today you would earn a total of 15.00 from holding Afya or generate 0.97% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Amgen Inc vs. Afya
Performance |
Timeline |
Amgen Inc |
Afya |
Amgen and Afya Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Amgen and Afya
The main advantage of trading using opposite Amgen and Afya positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Amgen position performs unexpectedly, Afya can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Afya will offset losses from the drop in Afya's long position.Amgen vs. Puma Biotechnology | Amgen vs. Iovance Biotherapeutics | Amgen vs. Day One Biopharmaceuticals | Amgen vs. Inozyme Pharma |
Afya vs. Adtalem Global Education | Afya vs. Laureate Education | Afya vs. American Public Education | Afya vs. Strategic Education |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Other Complementary Tools
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data |